The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Category: Bancel, Stephane
-
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
The New York Times – Business:
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.